Anticancer agent 249 (Compound 89) is an inhibitor for Hsp90beta with IC50 of 16.5 µM in PC3MM2 cell. Anticancer agent 249 inhibits proliferation of cancer cells MCF-7, T47D, MDA-MB-231, MDA-MB-468 and SKBr3 with IC50 of 1.8-5.3 µM. Anticancer agent 249 induces apoptosis in MDA-MB-231. Anticancer agent 249 exhibits antitumor efficacy in mice[1].
Molekulargewicht:
476.44
Formel:
C25H31Cl2N3O2
Target-Kategorie:
Apoptosis,HSP
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
